HEPATITIS A

PREVENTION RELIES PRIMARILY ON

  • Drinking safe water

  • Prudent hygiene

  • Avoiding uncooked shellfish, fruits and vegetables, ice in endemic areas.

IMMUNOGLOBULINS (0.02 ml/kg), a preparation of antibodies is recommended for short-term protection against hepatitis A and for persons who have already been exposed to HAV.
Immunoglobulins must be given within two weeks after exposure to HAV. They protect for approximately two months.

HEPATITIS A VACCINE which provides long-term protection for individuals older than two years of age.

Indication for Hepatitis A vaccination

  • Persons who work in or travel to areas where hepatitis A is endemic (first dose should be given at least four weeks before travel)

  • Homosexual men

  • Persons who use street drugs

  • Persons with chronic liver diseases, such as hepatitis B or C

  • Children in certain high risk communities.


HEPATITIS B

PREVENTION RELIES PRIMARILY ON

  • Screening of blood and blood products

  • Use of disposable needles

  • Adequate sterilization of surgical or dental instruments
  • Use of precautions and barrier techniques (such as wearing of gloves, eye/face protection etc.)
  • Education about the risks of using unsterilized material.

HEPATITIS B IMMUNE GLOBULINS(H-BIG) are administered for temporary passive protection from hepatitis B. Unvaccinated health care workers after a needle stick injury from a patient infected with HBV and sexual partners of individuals with acute hepatitis B should receive H-BIG and start the hepatitis B vaccination. Infants born from HBV infected mothers should also be treated with both H-BIG and vaccine.

HEPATITIS B VACCINE: there is a safe and effective vaccine for hepatitis B. In many countries the administration of hepatitis B vaccine is compulsory for newborns and for 12 year old children.

Indication for Hepatitis B vaccination

  • health care and emergency personnel
  • people with multiple sexual partners
  • drug users
  • hemodialysis patients
  • sexual partners and household members of HBV carriers
  • patients with chronic liver diseases


HEPATITIS C

There is currently no vaccine for HCV. The difficulty in developing a vaccine is due, particularly to the mutability of the virus. Moreover there is no effective short-term prevention such as immune globulin.
Recommendations on measures to prevent HCV infection include :

  • Screening of blood and blood products
  • Use of disposable needles
  • Adequate sterilization of surgical or dental instruments
  • Use of precautions and barrier techniques (such as wearing of gloves, eye/face protection etc.)
  • Education about the risks of using unsterilized material


HEPATITIS D

There is no vaccine for HDV. Since HDV is dependent on HBV for replication the most important method for preventing HBV-HDV coinfection is immunization with hepatitis B vaccine. It is also necessary following profilactic recommendation for HBV infection.


HEPATITIS E

There is no vaccine or immune globulin available to prevent the trasmission of HEV. Prevention relies primarily on:

  • Drinking safe water
  • Prudent hygiene
  • Avoiding uncooked shellfish, fruits and vegetables, ice in endemic areas.

 

©2001 IdéoDeveloped by NetvisionDisclaimerPrivacy